View BPC-157 What is the recommended BPC-157 dose for fibromyalgia
How GLP-1 Drugs Drive Innovation Driven by their effectiveness in managing diabetes and promoting weight loss, demand for glucagon-like peptide-1 drugs, known as GLP-1s, is surging globally
Glucagon-like Peptide-1 Receptor Dependent Signaling in Cardiovascular Health and Disease: A Mini-review
For the primary composite outcome and secondary hierarchical outcomes, the threshold for two-sided statistical significance was set to 0.0322 (one-sided level 0.00161) using Lan-DeMets alpha spending function, which allows to adjust significance levels as data were reviewed for the interim analysis, reducing the chance of false positive results
Patients who experienced difficulty tolerating standard doses with previous providers sometimes find success with Brightmeds microdosing protocols
Similar to weight loss studies, people with type 2 diabetes who took the 25 mg and 50 mg doses lost more weight than those taking the current 14 mg dose